ArticleScience (New York, N.Y.)2023

Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease.

Simon Lebek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.